MARKET

JBIO

JBIO

Jade Biosciences Inc
NASDAQ
13.50
+1.10
+8.87%
After Hours: 13.50 0 0.00% 17:01 12/05 EST
OPEN
12.42
PREV CLOSE
12.40
HIGH
14.24
LOW
12.10
VOLUME
534.93K
TURNOVER
--
52 WEEK HIGH
14.24
52 WEEK LOW
1.016
MARKET CAP
621.06M
P/E (TTM)
-1.1791
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 1d ago
Does Jade Biosciences, Inc. (JBIO) Have the Potential to Rally 65% as Wall Street Analysts Expect?
NASDAQ · 2d ago
Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Boston Scientific (BSX)
TipRanks · 4d ago
Weekly Report: what happened at JBIO last week (1124-1128)?
Weekly Report · 6d ago
Jade Biosciences Price Target Announced at $25.00/Share by Clear Street
Dow Jones · 11/25 12:37
Jade Biosciences Initiated at Buy by Clear Street
Dow Jones · 11/25 12:37
Clear Street Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $25
Benzinga · 11/25 12:27
Jade Biosciences initiated with a Buy at Clear Street
TipRanks · 11/24 21:36
More
About JBIO
Jade Biosciences, Inc. is a biotechnology company, which is focused on developing therapies for autoimmune diseases. The Company’s lead asset, JADE-001, is an investigational anti-A PRoliferation-Inducing Ligand (APRIL) monoclonal antibody for the treatment of Immunoglobulin A (IgA) nephropathy (IgAN), an autoimmune condition in which the kidney is damaged by pathogenic IgA containing immune complexes, leading to proteinuria and kidney function decline, and potentially progressing to end-stage kidney disease requiring dialysis or transplantation. Designed to block the APRIL protein, JADE-001 targets an underlying cause of IgAN, offering the potential to reduce pathogenic IgA levels, decrease proteinuria, and preserve kidney function over the long term. The Company’s pipeline also includes two undisclosed antibody discovery programs: JADE-002 and JADE-003, which are in preclinical development.

Webull offers Jade Biosciences Inc stock information, including NASDAQ: JBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JBIO stock methods without spending real money on the virtual paper trading platform.